Thioredoxin-2 impacts the inflammatory response via suppression of NF-κB and MAPK signaling in sepsis shock

Area of Science:

• Immunology
• Molecular Biology
• Pathophysiology

Background:

• Sepsis is a life-threatening condition driven by excessive inflammation and organ dysfunction.
• Understanding molecular regulators of sepsis is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the role of thioredoxin-2 (TRX-2) in regulating inflammatory responses during sepsis.
• To determine if TRX-2 can mitigate sepsis-induced mortality and organ injury.

Main Methods:

• Assessed TRX-2 expression in lipopolysaccharide (LPS)-stimulated macrophages.
• Overexpressed TRX-2 in macrophages and evaluated its effect on inflammatory cytokine production (IL-6, TNF-α).
• Investigated the impact of TRX-2 on NF-κB and MAPK signaling pathways.
• Evaluated the therapeutic effect of TRX-2 in mouse models of sepsis, assessing mortality and organ damage.

Main Results:

• LPS stimulation led to reduced TRX-2 expression in macrophages.
• TRX-2 overexpression significantly attenuated LPS-induced IL-6 and TNF-α production.
• TRX-2 suppressed the activation of NF-κB and MAPK signaling pathways.
• TRX-2 overexpression decreased mortality and attenuated organ injury in mouse sepsis models.

Conclusions:

• TRX-2 acts as a critical negative regulator of inflammatory responses in sepsis.
• TRX-2 protects against sepsis-induced mortality and organ damage by inhibiting excessive inflammation.
• TRX-2 represents a potential therapeutic target for managing sepsis.